新横浜パチスロ News

Top
News
新横浜パチスロ signed a License Agreement with Almirall on COPD Therapeutic Agent "Aclidinium Bromide" for Japan Territory

新横浜パチスロ signed a License Agreement with Almirall on COPD Therapeutic Agent "Aclidinium Bromide" for Japan Territory

February 24, 2011

Please see the PDF file below for details.

新横浜パチスロ signed a License Agreement with Almirall on COPD Therapeutic Agent "Aclidinium Bromide" for Japan Territory [ 15.6 KB ]